Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.47.7.2264-2272.2003PMID 12821478PMCID PMC161875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network

  2003cited by this paper
• The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

  2002cited by this paper
• Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets.

  2002cited by this paper
• The value of a database in surveillance and vaccine selection

  2001cited by this paper
• Position statement: global neuraminidase inhibitor susceptibility network.

  2001cited by this paper
• Treatment of influenza with neuraminidase inhibitors: virological implications.

  2001cited by this paper
• Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants

  2001cited by this paper
• Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

  2001cited by this paper
• Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

  2001cited by this paper
• Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.

  2000cited by this paper
• Incidence of Amantadine‐Resistant Influenza A Viruses in Sentinel Surveillance Sites and Nursing Homes in Niigata, Japan

  2000cited by this paper
• Resistance of influenza viruses to neuraminidase inhibitors--a review.

  2000cited by this paper
• Management of Influenza

  2000influential reference
• Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.

  2000influential reference
• Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

  2000cited by this paper
• Development of a sensitive neuraminidase assay for the determination of influenza virus susceptibility to NA inhibitors

  1999cited by this paper
• Low incidence of rimantadine resistance in field isolates of influenza A viruses.

  1999cited by this paper
• Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design.

  1998influential reference
• Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors

  1998cited by this paper
• Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.

  1998cited by this paper
• Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.

  1998cited by this paper
• Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996).

  1997cited by this paper
• Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.

  1997cited by this paper
• Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en

  1997cited by this paper
• Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme.

  1996cited by this paper
• Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.

  1995cited by this paper
• Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.

  1995cited by this paper
• Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.

  1995cited by this paper
• Rational design of potent sialidase-based inhibitors of influenza virus replication

  1993cited by this paper
• Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution.

  1991cited by this paper
• Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.

  1989cited by this paper
• Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

  1979cited by this paper

• Reverse genetic rescue and propagation of human influenza A(H3N2) master virus seed in HEK-293 suspension cells.

  2026cites this paper
• Cross-Species Transmission Potential of H4 Avian Influenza Viruses in China: Epidemiological and Evolutionary Study

  2024cites this paper
• Global trends of seasonal influenza-associated mortality in 2001-2018: A longitudinal epidemiological study.

  2023cites this paper
• New insights into the neuraminidase-mediated hemagglutination activity of influenza A(H3N2) viruses.

  2023cites this paper
• Recent Efforts in Identification of Privileged Scaffolds as Antiviral Agents

  2023cites this paper
• Pyocyanin as a safe aquaculture drug for the control of vibriosis in shrimp recirculating aquaculture system (RAS)

  2022cites this paper
• Population analysis of oseltamivir-resistant variants for the rapid prediction of drug susceptibility by real-time reverse transcription polymerase chain reaction

  2022cites this paper
• Evaluation of Neuraminidase Inhibitory Activity of Compounds and Extracts from Traditional Medicines by HPLC-FLD

  2021cites this paper
• Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.

  2021influential citation
• Source of oseltamivir resistance due to single E276D, R292K, and double E276D/R292K mutations in H10N4 influenza neuraminidase

  2021cites this paper
• Antiviral Drugs Against Influenza Virus

  2021cites this paper
• Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia

  2021cites this paper
• Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs

  2021cites this paper
• Genetic sequencing of influenza A (H1N1) pdm09 isolates from South India, collected between 2011 and 2015 to detect mutations affecting virulence and resistance to oseltamivir

  2020cites this paper
• Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding

  2020cites this paper
• Alterations in photosynthetic pigments, antioxidant machinery, essential oil constituents and growth of menthol mint (Mentha arvensis L.) upon nickel exposure

  2020cites this paper
• INFLUENZA AND VIRAL RESPIRATORY INFECTIONS

  2020cites this paper
• Intravenous Zanamivir: A Viable Option for Critically Ill Patients With Influenza

  2020cites this paper
• Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility

  2020cites this paper
• Selection of avian influenza A (H9N2) virus with reduced susceptibility to neuraminidase inhibitors oseltamivir and zanamivir.

  2019cites this paper
• New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways.

  2019cites this paper
• Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.

  2019cites this paper
• Infection and Drug Resistance Dovepress

  2019cites this paper
• A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses

  2019cites this paper
• Structural insight into the mechanism of neuraminidase inhibitor-resistant mutations in human-infecting H10N8 Influenza A virus

  2018cites this paper
• Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

  2018cites this paper
• Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility

  2018cites this paper
• Influenza virus susceptibility to antiviral drugs : drug susceptibility profiling, whole-genome mutational landscape and selective pressure footprints

  2018cites this paper
• Prescription – Pollution – Poo – Pandemics - Priorities : Neuraminidase Inhibitors from an Environmental Resistance Development Perspective

  2018cites this paper
• Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility

  2018cites this paper
• Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance

  2018cites this paper
• Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.

  2018cites this paper
• Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus

  2018cites this paper
• Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.

  2017cites this paper
• Antimicrobial Drug Resistance

  2017cites this paper
• Antirespiratory Virus Agents

  2017cites this paper
• Synthesis and Anti‐influenza Virus Activity of Novel bis(4H‐chromene‐3‐carbonitrile) Derivatives

  2017cites this paper
• Cooperating H3N2 Influenza Virus Variants Are Not Detectable in Primary Clinical Samples

  2017cites this paper
• Genomic signature analysis of the recently emerged highly pathogenic A(H5N8) avian influenza virus: implying an evolutionary trend for bird-to-human transmission.

  2017cites this paper
• Drug resistance in influenza A virus: the epidemiology and management

  2017influential citation
• Resistance to Influenza Neuraminidase Inhibitors

  2017cites this paper
• Development of Novel Anti-Respiratory Syncytial Virus Therapies

  2017cites this paper
• Genomic characterization of influenza A (H7N9) viruses isolated in Shenzhen, Southern China, during the second epidemic wave

  2016cites this paper
• Approved Antiviral Drugs over the Past 50 Years

  2016cites this paper
• Respiratory Virus Infections

  2016cites this paper
• Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture

  2016cites this paper
• Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms

  2016cites this paper
• Prediction of selective inhibition of neuraminidase from various influenza virus strains by potential inhibitors

  2016cites this paper
• Sensitive Detection and Simultaneous Discrimination of Influenza A and B Viruses in Nasopharyngeal Swabs in a Single Assay Using Next-Generation Sequencing-Based Diagnostics

  2016cites this paper
• Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

  2016cites this paper
• Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza – review of recent systematic reviews and meta-analyses

  2016cites this paper
• Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance.

  2016cites this paper
• [Prediction of selective inhibition of neuraminidase from various influenza virus strains by potential inhibitors].

  2016cites this paper
• Detection and Molecular Characterization of the Avian Influenza A (H7N9) Virus in Eastern China in 2013

  2016cites this paper
• In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection.

  2016cites this paper
• Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects.

  2016cites this paper
• In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.

  2015cites this paper
• Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.

  2015cites this paper
• Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry.

  2015cites this paper
• Evaluation of Safety and Efficacy of Intravenous Zanamivir in the Treatment of Hospitalized Japanese Patients with Influenza: An Open-Label, Single-Arm Study

  2015cites this paper
• Mechanisms of resistance to neuraminidase inhibitors in influenza A viruses and evaluation of combined antiviral therapy

  2015cites this paper
• An overview of the characteristics of the novel avian influenza A H7N9 virus in humans

  2015cites this paper
• Application of a Seven-Target Pyrosequencing Assay To Improve the Detection of Neuraminidase Inhibitor-Resistant Influenza A(H3N2) Viruses

  2015cites this paper
• Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.

  2015cites this paper
• Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.

  2015cites this paper
• Susceptibility Test Methods: Viruses*

  2015cites this paper
• Characterization of Neuraminidase gene of Avian Influenza virus (H5N1) In Egypt from 2006-2009

  2015cites this paper
• Control of Avian Influenza in Poultry with Antivirals and Molecular Manipulation

  2015cites this paper
• Sequential Influenza B Viral Load and Susceptibility in Children Treated With Oseltamivir and Zanamivir

  2014cites this paper
• Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009

  2014cites this paper
• The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses.

  2014cites this paper
• Antiviral Drugs for Influenza and Other Respiratory Virus Infections

  2014cites this paper
• Epidemiological and Virological Characteristics of Influenza Viruses Circulating in Cambodia from 2009 to 2011

  2014cites this paper
• Assessment of the potential of a narrow spectrum kinase inhibitor in the treatment of influenza infection

  2014cites this paper
• Genetic characterization of influenza A virus subtype H7N1 isolated from quail, Thailand

  2014cites this paper
• Y155H amino acid substitution in influenza A(H1N1)pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors.

  2014cites this paper
• A Crucial Epitope in the Influenza A and B Viral Neuraminidase and its Broad Inhibition by a Universal Antibody

  2014cites this paper
• Antiviral resistance in influenza viruses: laboratory testing.

  2014cites this paper
• In vitro and in vivo anti-influenza virus activities of flavonoids and related compounds as components of Brazilian propolis (AF-08)

  2014cites this paper
• The development and application of pyrosequencing assays to determine antiviral susceptibility of Influenza A to neuraminidase inhibitors.

  2014influential citation
• A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade

  2014cites this paper
• Surveillance and outbreak reports Y 155 H amino acid substitution in influenza A ( H 1 N 1 ) pdm 09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors

  2014cites this paper
• Respiratory Viral Infections in Immunocompromised Patients

  2013cites this paper
• Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study

  2013cites this paper
• Evaluation of influenza virus antiviral susceptibility testing in Europe: results from the first external quality assessment exercise.

  2013cites this paper
• Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

  2013cites this paper
• Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria

  2013cites this paper
• Comparison of Mutation Patterns in Full-Genome A/H3N2 Influenza Sequences Obtained Directly from Clinical Samples and the Same Samples after a Single MDCK Passage

  2013cites this paper
• Influenza virus resistance to neuraminidase inhibitors.

  2013cites this paper
• Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season

  2013cites this paper
• I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses

  2013influential citation
• Virus Susceptibility Analyses from a Phase IV Clinical Trial of Inhaled Zanamivir Treatment in Children Infected with Influenza

  2013cites this paper
• Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay system

  2013cites this paper
• Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry

  2013cites this paper
• Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

  2013cites this paper
• Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

  2013influential citation
• Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China.

  2013cites this paper
• The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities

  2013cites this paper
• Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.

  2013cites this paper
• Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses

  2013cites this paper